Article Access statistics

Viewed: 852

Emailed: 0

PDF Downloaded: 268

Indian Journal of Pharmacy and Pharmacology

Assessment of health related quality of life of drug resistant tuberculosis patients

Full Text PDF Share on Facebook Share on Twitter

Author Details : Sonia Dhiman, Rekha Bansal, Dinesh Kansal, Parveen K. Sharma

Volume : 5, Issue : 2, Year : 2018

Article Page : 62-65

Suggest article by email


 Objectives: Assessment of Health Related Quality of Life (HRQoL) of drug resistant tuberculosis patients at the start of treatment under PMDT regime.
Materials and Methods: This observational study was conducted on a cohort of 172
drug resistant tuberculosis (DR-TB) patients at the time of registration under PMDT regime. Patients who started their treatment between January 2016 and December 2016 were included in the study after approval from IEC. A validated WHOQOL-BREF questionnaire was used for interviewing the patients. This questionnaire assesses HRQoL on 0-100 transforming scale in four domains – Physical, Psychological, Social relationship and Environmental.
Results: Out of 172 participants, 50 (29.1%) were females and 122(70.9%) were males. Their mean age±SD was 40.23±15.77 years. 77.9% participants were married. 97.7% of them were residing in rural areas. Most of the participants were from district Mandi (33.1%) and Kangra (20.9%). Scores of Physical domain were 39.76±13.88; Psychological domain were 37.23±14.89; Social relationship domain were 43.28±13.48 and Environment domain were 50.66±9.13. Overall HRQoL scores were 42.73±10.11.
Conclusion: Chronic diseases like tuberculosis affect all domains of HRQoL and there is need to consider HRQoL domains of patients of DR-TB along with smear positivity and mortality to evaluate the success of any national heath programme.

Keywords:Drug resistant tuberculosis, Health related quality of life, WHO-QOL BREF



Doi : 10.18231/2393-9087.2018.0014

How to cite : Dhiman S, Bansal R, Kansal D, Sharma P K, Assessment of health related quality of life of drug resistant tuberculosis patients. Indian J Pharm Pharmacol 2018;5(2):62-65

Copyright © 2018 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (